Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Norwegian Cruise Line Holdings Ltd (NCLH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Norwegian Cruise Line Holdings Ltd — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Norwegian Cruise Line Holdings Ltd trades at $14.88 (market cap $7.03B). The key difference: Hinge Health Inc. Class A Common Stock is the larger of the two by market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Norwegian Cruise Line Holdings Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Norwegian Cruise Line Holdings Ltd for 69 Days on average.
| HNGE | NCLH | |
|---|---|---|
Market Cap | $8.48B | $7.03B |
Volume | 879,799 | 12,698,429 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.14 | $25.02 |
52-Week Low | $31.17 | $14.12 |
Typical Hold Time | 0 Days | 69 Days |
Enterprise Value | $8.10B | $21.85B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Norwegian Cruise Line Holdings (NCLH) trades at $14.87, down 3.13% today, with mixed technical signals showing neutral overall but bearish moving averages. The company demonstrates strong fundamental recovery with Q2 2026 EPS beating expectations at $0.48 versus $0.41, and maintains positive cash flow trends. Recent news highlights management's expectation for Q3 2026 results to exceed guidance, while facing yield pressure through 2027.
NCLH presents a compelling value opportunity with a low P/E of 9.28 and strong analyst consensus price target of $20.86 (40% upside), though elevated debt levels and Caribbean pricing pressure pose near-term risks. The stock's investment case hinges on continued operational execution and demand stabilization amid industry headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Norwegian Cruise Line Holdings Ltd
Norwegian Cruise Line is the world's third-largest cruise company by berths (at more than 62,000), operating 29 ships across three brands (Norwegian, Oceania, and Regent Seven Seas), offering both freestyle and luxury cruising. The company has redeployed its entire fleet as of May 2022. With eight passenger vessels on order among its brands through 2027 (representing 20,000 incremental berths), Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sailed to around 500 global destinations before the pandemic.
Read more on NCLH →
